Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors

Table 4

Cox regression analyses: time until first dispensing date of levodopa for patients 72 years or above, the final model (baseline in parentheses).

Variable	HR	CI	value
Age	0.924	(0.91, 0.938)	<0.001
Gender (male)	0.609	(0.523, 0.708)	<0.001
Drugs for diabetes (none)	0.693	(0.513, 0.935)	0.016
Drugs for hypothyroidism (none)	1.207	(0.963, 1.513)	0.102
Dopamine agonist user (MAO-B inhibitor user)	0.064	(0.055, 0.075)	<0.001